BUY Fortis Healthcare — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))10 Jun 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
4 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·10 Jun · yesterday
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·22 Apr · 2mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Fortis Healthcare
- SELL — Manas Jaiswal14 Oct 2026 · ~2 weeks · target ₹660 · Active
- BUY — HSBC Securities9 Oct 2026 · ~1 year · target ₹950 · Active
- SELL — Mahesh Ojha, Kantilal Chhaganlal Securities27 Sept 2026 · ~2 weeks · target ₹820 · Target hit
- SELL — Manas Jaiswal25 Sept 2026 · ~2 weeks · target ₹825 · Target hit
- BUY — Nomura India Research7 Sept 2026 · ~1 year · target ₹1,030 · Active
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

